Mason, Pamela K <br/><br/>
Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.  [electronic resource] 

 -  The American journal of medicine  Jun 2012 
 - 603.e1-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1555-7162 
<br/><br/><label>Standard No.: </label>10.1016/j.amjmed.2011.09.030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--complications<br/>Comorbidity<br/>Diabetes Complications--epidemiology<br/>Drug Administration Schedule<br/>Europe<br/>Female<br/>Heart Failure--complications<br/>Hemorrhage--chemically induced<br/>Humans<br/>Hypertension--complications<br/>Male<br/>Middle Aged<br/>Practice Guidelines as Topic--standards<br/>Predictive Value of Tests<br/>Primary Prevention--methods<br/>Propensity Score<br/>Risk Assessment<br/>Risk Factors<br/>Secondary Prevention--methods<br/>Sex Factors<br/>Societies, Medical<br/>Stroke--epidemiology<br/>United States<br/>Warfarin--administration & dosage